Electronic Patient Decision Support System for Patients with Type 2 Diabetes (DiaPaDeSS)

Launched by AKDENIZ UNIVERSITY · Jun 5, 2023

Keywords

ClinConnect Summary

The DiaPaDeSS trial is studying a new electronic system designed to help people with type 2 diabetes manage their condition better at home. This system provides educational resources and guidance on important self-management tasks, like monitoring blood sugar levels, measuring blood pressure, and taking medications. The goal is to empower patients to take an active role in their health, which can lead to better overall health and control of diabetes. The trial will involve two groups of participants; one group will use the new system fully, while the other will use only part of it for comparison.

To be eligible for this study, participants must be between 18 and 65 years old, have been diagnosed with type 2 diabetes for at least six months, and have internet access along with the ability to use a computer, tablet, or smartphone. They should also be able to understand their diagnosis and communicate about it. Participants will be involved for three months, during which their progress will be monitored to see how well the DiaPaDeSS helps them improve their self-management and health outcomes. This trial is not yet recruiting, so more information will be available as it progresses.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with type 2 diabetes who had been followed up and treated at the Endocrinology and Metabolic Diseases Polyclinic
• • Aged between 18-65 years
• • Patients who know their diagnosis and can verbally express it
• • Have been diagnosed with type 2 diabetes for at least six months
• • Who are literate
• • Who have internet access at home, who have one of the tools such as a computer, tablet or smartphone and can use these tools
• • Consented to participate in the study
• • Had no other psychiatric or mental barriers to answering the questions, language or cognitive difficulties, and barriers to verbal or written communication
• Exclusion Criteria:
• • Diagnosed with myocardial infarction, stroke or diabetic foot in the last six months
• • Diagnosed with type 1 diabetes or gestational diabetes
• • Diagnosed with terminal illness
• • Using steroid therapy
• • Had pregnant
• • Having dementia and cognitive deficits
• • Having retinopathy or advanced neuropathy
• • Patients whose information is not allowed to be accessed